Apr 06, 2005
Notice
Kringle Pharma concluded a joint research agreement and a license agreement with Nippon Zenyaku Kogyo to place HGF-based drugs for animal use on the market at an early date.
Kringle Pharma concluded a joint research agreement and a license agreement with Nippon Zenyaku Kogyo to place HGF-based drugs for animal use on the market at an early date.